Reddy BG, Silk JD, Salio M, Balamurugan R, Shepherd D, Ritter G, Cerundolo V, Schmidt RR. Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.
ChemMedChem 2009;
4:171-5. [PMID:
19160440 DOI:
10.1002/cmdc.200800354]
[Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
Based on the crystal structures of human alpha-GalCer-CD1d and iNKT-alpha-GalCer-CD1d complexes, nonglycosidic analogues of alpha-GalCer were synthesized. They activate iNKT cells resulting in dendritic cell maturation and the priming of antigen-specific T and B cells. Therefore, they are attractive adjuvants in vaccination strategies for cancer and infectious diseases.
Collapse